Oric Pharmaceuticals, Inc.

Q1 2022 13F Holders

Symbol: ORIC
CUSIP: 68622P109
Type: Equity
Class: COM
Num filings: 105
Total reported value, excl. options: $182 M

Compare 2022 Q1 to

Manager	Report Date	Value ($000)	Shares	Option Type